SkinbiotherapeuticsSBTX 
$0.14-0.94%24h
-0.94%24h
Global rank28628
Market cap$22.88M
Change 7d-16.63%
YTD Performance-30.98%
SP500 benchmarkUnderperform
P/E-8.08
P/S131.28
Revenue$174.32K
Earnings-$3.74M
Dividend yield-
Main Sector
Healthcare
Category
Skinbiotherapeutics (SBTX) Cash on Hand
SBTX Cash on Hand in 2022: $1.73M
According to Skinbiotherapeutics latest financial reports the cash on hand of SBTX is $1.73M, an decrease of -27.32% to 2022. At the end of 2022 company had $2.38M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
SBTX Cash on Hand History from 2019 to 2023
-
Value:-
SBTX Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $1.73M | -27.32% |
| 2022 | $2.38M | -60.85% |
| 2021 | $6.09M | 113.51% |
| 2020 | $2.85M | -30.91% |
| 2019 | $4.12M | - |
View the Top Cash on Hand Companies 
